Business
CareDx Presents Latest Advancements at 12th Congress of the International Pediatric Transplant Association
CareDx to Host Symposium Featuring the Latest Developments in Pediatric Transplant Care BRISBANE, Calif.--(BUSINESS WIRE)-- CareDx, Inc. (Nasdaq: CDNA), a
About this update from Caredx, Inc.
[{"type":"text","content":"\nCareDx to Host Symposium Featuring the Latest Developments in Pediatric Transplant Care\n\n BRISBANE, Calif.--(BUSINESS WIRE)--\nCareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced its gold-level sponsorship and participation at the 12th Congress of the International Pediatric Transplant Association (IPTA) taking place March 25-28, 2023, in Austin, Texas.\n\n“CareDx is 100% committed to driving transplant innovation and this is especially important for pediatric patients who require decades of graft function. We’ve helped advance the field by being included in the first pediatric publications demonstrating the value of non-invasive monitoring with AlloSure® in heart and kidney, and AlloMap® in heart,” said Reg Seeto, CEO and President of CareDx. “We are very proud to once again be one of the lead sponsors for the 12th Congress of the IPTA – an organization at the forefront of advancing science and technology for pediatric patients.”\n\nCareDx will host a symposium highlighting the company’s latest developments in pediatric heart and kidney transplant patient care. The symposium, “Paradigm Shifts in Pediatric Surveillance Testing: AlloSure and AlloMap in Action” will be held on Sunday, March 26, from 12:30 – 1:30pm CDT. Speakers include:\n\n\nRaja S. Dandamudi, MD, Assistant Professor, Pediatric Nephrology, Washington University School of Medicine, St. Louis\n\n\nBrian D. Feingold, MD, MS, FAHA, Associate Professor of Pediatrics and Clinical and Translational Science, Medical Director, Heart Failure and Transplantation Programs, UPMC Children's Hospital of Pittsburgh\n\n\nDechu Puliyanda, MD, Professor, Director Pediatric Nephrology, Medical Director Children’s Health Center, Cedars-Sinai, Pediatrics\n\n\nDaniel Ranch, MD, MBA, Clinical Associate Professor, Pediatric Nephrologist in the Department of Pediatrics, UT Health San Antonio\n\n\n“I look forward to sharing the results from our center Washington University/St. Louis children’s hospital research with AlloSure at the 12th annual Congress of the IPTA during my presentation, Longitudinal Evaluation of AlloSure in Pediatric Kidney Transplantation,” said Raja S. Dandamudi, MD, Assistan...